Lusduna Европейски съюз - български - EMA (European Medicines Agency)

lusduna

merck sharp & dohme b.v. - инсулин гларжин - Захарен диабет - Лекарства, използвани при диабет - Лечение на захарен диабет при възрастни, юноши и деца на възраст над 2 години.

NuvaRing 0,120 mg/0,015 mg per 24 hours, vaginal delivery system България - български - Изпълнителна агенция по лекарствата

nuvaring 0,120 mg/0,015 mg per 24 hours, vaginal delivery system

nv organon - вагинален пръстен с прогестагеном и естроген - 0,120 mg/0,015 mg per 24 hours, vaginal delivery system

Pharmatex 1,2% vaginal cream България - български - Изпълнителна агенция по лекарствата

pharmatex 1,2% vaginal cream

laboratoire innotech international - Интравагинально контрацептиви - 1,2% vaginal cream

Gynoflor  vaginal tablets България - български - Изпълнителна агенция по лекарствата

gynoflor  vaginal tablets

pharmaswiss ceska republika s.r.o., - Естриол, бактерии lactobacillus acidophillus - vaginal tablets

Spikevax (previously COVID-19 Vaccine Moderna) Европейски съюз - български - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Ваксини - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.